GlycoMimetics,
Inc. announced today that the Tech
Council of Maryland (TCM) named Rachel K. King, GlycoMimetics Chief
Executive Officer, as the winner ... read more
GlycoMimetics,
Inc. (GMI) today announced top line clinical results from a Phase 2
study of GMI-1070 in patients experiencing vaso-occlusive crisis (VOC)
... read more
GlycoMimetics,
Inc. (GMI), a clinical-stage biotechnology company researching a new
class of glycobiology-based therapies for a broad range of diseases,
today announced ... read more